What is the recommended treatment for Catheter-Related Bloodstream Infection (CRBSI) caused by Burkholderia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Catheter-Related Bloodstream Infection (CRBSI) Caused by Burkholderia

Remove the infected catheter immediately for any CRBSI caused by Burkholderia species, as catheter retention has unacceptably high failure rates similar to Pseudomonas infections. 1

Immediate Catheter Management

  • The catheter must be removed immediately for Burkholderia CRBSI, regardless of whether it is a short-term or long-term catheter 1
  • For hemodialysis catheters specifically, insert a temporary catheter at a different anatomical site immediately after removal 1
  • Guidewire exchange should only be considered as an absolute last resort if no alternative vascular access sites exist, though catheter removal remains strongly preferred 1
  • The IDSA guidelines explicitly exclude Pseudomonas and similar organisms like Burkholderia from catheter salvage protocols, even in patients with limited vascular access, due to high failure rates 1

Critical distinction: Unlike coagulase-negative staphylococci or some other gram-negative organisms where catheter salvage may be attempted, Burkholderia behaves like Pseudomonas with similar virulence and biofilm-forming capacity, making retention futile 1

Empirical Antibiotic Therapy

  • Start vancomycin PLUS a broad-spectrum gram-negative agent immediately while awaiting susceptibility results 1
  • Acceptable gram-negative coverage options include: fourth-generation cephalosporin (cefepime), carbapenem (meropenem or imipenem), or β-lactam/β-lactamase combination (piperacillin-tazobactam) 1
  • For severely ill or immunocompromised patients, use empirical combination therapy targeting multi-drug resistant gram-negative bacilli until culture data allows de-escalation 1

Duration of Antibiotic Therapy

For uncomplicated infections:

  • Treat for 10-14 days after catheter removal if clinical and microbiological response occurs within 48-72 hours 1, 2

For complicated infections or treatment failure:

  • If bacteremia persists >72 hours after catheter removal despite appropriate antibiotics, extend therapy to 4-6 weeks 1, 2
  • Treat for 4-6 weeks if endocarditis, suppurative thrombophlebitis, or osteomyelitis develops 1, 2

Monitoring and Follow-Up

  • Obtain repeat blood cultures 72 hours after initiating therapy to document clearance 1
  • Persistent positive cultures at 72 hours indicate treatment failure and suggest metastatic infection requiring extended therapy 1
  • For hemodialysis patients, a long-term catheter can be placed once blood cultures are negative 1

Common Pitfalls to Avoid

  • Do not attempt catheter salvage with antibiotic lock therapy for Burkholderia CRBSI—this approach has unacceptably high failure rates and is associated with increased mortality 1
  • Do not delay catheter removal while waiting for culture results if Burkholderia is suspected based on clinical context or Gram stain 1
  • Do not use short-course therapy (≤7 days) for Burkholderia CRBSI, as this organism requires the full 10-14 day course minimum 1, 2
  • Do not assume clinical improvement means microbiological cure—always obtain follow-up blood cultures at 72 hours to confirm clearance 1

References

Guideline

Management of Catheter-Related Bloodstream Infection (CRBSI) Caused by Burkholderia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Duration of Meropenem for Catheter-Related Bloodstream Infections (CRBSI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.